Edwards Lifesciences Corp — Director's Dealing 2021

Dec 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-12-17

Reporting Person: Szyman Catherine M. (CVP, Critical Care)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-17	Common Stock	M	10000.0000	$21.7600	Acquired	37414.5223	Direct
2021-12-17	Common Stock	S	10000.0000	$121.2400	Disposed	27414.5223	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-17	Employee Stock Option (Right to Acquire)	$21.7600	M	10000.0000	Disposed	2022-05-13	Common Stock (10000.0000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.